We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ronald Witteles

Ronald Witteles MD

Professor of Medicine (Cardiovascular Medicine), Stanford University School of Medicine; Co-Director, Stanford Amyloid Center; Program Director, Internal Medicine Residency Training Program, Stanford University, Stanford, California

Ronald Witteles, MD, is Professor of Medicine (Cardiovascular Medicine) at the Stanford University School of Medicine.  He is Co-Director of the Stanford Amyloid Center, one of the largest Amyloid Centers in the world and the largest in the Western United States.  He additionally serves as Co-Director of the Stanford Multidisciplinary Sarcoidosis Program, and he has headed the CardioOncology clinic at Stanford for over a dozen years.   In addition, Dr. Witteles has served as Program Director of the Internal Medicine Residency Training Program at Stanford, a position he has held for 11 years, in which he directly supervises the training of over 140 Internal Medicine residents and provides oversight for all of the fellowship programs within the Department of Medicine.  Dr. Witteles serves as an Associate Editor for JACC: CardioOncology, and he has published extensively in the fields of Amyloidosis, CardioOncology, and Sarcoidosis. 

Disclosures

Dr. Witteles is on the advisory boards for Pfizer and Alnylam.